EL Stock Analysis: Estee Lauder Companies | NYSE
Household & Personal Products | NYSE, USA | Market Cap: 36.247m USD | 12M Return: 8.5% | US5184391044 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 270M
EPS Trend: 3.3%
Qual. Beats: 0
Rev. Trend: -66.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Estée Lauder Companies Inc. (NYSE: EL) is a global manufacturer and marketer of prestige beauty products spanning skin care, makeup, fragrance, and hair care categories. The company operates a multi-brand portfolio that includes La Mer, Clinique, M·A·C, TOM FORD, Jo Malone London, The Ordinary, Aveda, Bobbi Brown, and Too Faced, among others, with a portfolio approach that allows it to target distinct consumer segments and price points within the prestige beauty market.
The company distributes its products through a diversified channel mix that includes department stores, duty-free retailers (a key channel for global prestige beauty), specialty multi-brand retailers, pharmacies, salons, spas, freestanding stores, brand e-commerce sites, and third-party online platforms. Founded in 1946 and headquartered in New York, Estée Lauder has been publicly traded since its 1995 IPO and is classified within the Consumer Staples sector under the Personal Care Products sub-industry.
- China travel retail sales decline pressures prestige skincare revenue
- Fragrance segment growth driven by Tom Ford and Le Labo
- Inventory destocking and FX headwinds compress operating margins
| Net Income: 182.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 3.29 > 1.0 |
| NWC/Revenue: 9.18% < 20% (prev 11.41%; Δ -2.23% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.77b > Net Income 182.0m |
| Net Debt (7.69b) to EBITDA (1.65b): 4.67 < 3 |
| Current Ratio: 1.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (363.1m) vs 12m ago 0.67% < -2% |
| Gross Margin: 75.50% > 18% (prev 73.97%; Δ 1.53% > 0.5%) |
| Asset Turnover: 75.90% > 50% (prev 72.02%; Δ 3.88% > 0%) |
| Interest Coverage Ratio: 2.55 > 6 (EBIT TTM 851.0m / Interest Expense TTM 334.0m) |
| A: 0.07 (Total Current Assets 7.61b - Total Current Liabilities 6.23b) / Total Assets 19.8b |
| B: 0.57 (Retained Earnings 11.3b / Total Assets 19.8b) |
| C: 0.04 (EBIT TTM 851.0m / Avg Total Assets 19.8b) |
| D: 0.24 (Book Value of Equity 3.81b / Total Liabilities 16.0b) |
| Altman-Z'' = 2.87 = A |
| DSRI: 0.94 (Receivables 1.52b/1.53b, Revenue 15.0b/14.3b) |
| GMI: 0.98 (GM 73.97% / 75.50%) |
| AQI: 0.94 (AQ_t 0.36 / AQ_t-1 0.39) |
| SGI: 1.05 (Revenue 15.0b / 14.3b) |
| TATA: -0.08 (NI 182.0m - CFO 1.77b) / TA 19.8b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of October 15, 2026, the stock is trading at USD 101.59 with a total of 2,214,573 shares traded. Over the past week, the price has changed by +7.56%, over one month by +3.43%, over three months by +26.06% and over the past year by +8.46%.
Current recommended Stop Loss: 94.40 (which is 7.1% or 2.3 ATR below the current price).
Estee Lauder Companies has received a consensus analysts rating of 3.77. Therefore, it is recommended to hold EL.
- StrongBuy: 9
- Buy: 7
- Hold: 13
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 107.3 | 5.7% |
P/E Trailing = 200.08
P/E Forward = 29.7619
P/S = 2.4086
P/B = 9.3948
P/EG = 2.1211
Revenue TTM = 15.0b USD
EBIT TTM = 851.0m USD
EBITDA TTM = 1.65b USD
Long Term Debt = 6.80b USD (from longTermDebt, last quarter)
Short Term Debt = 902.0m USD (from shortTermDebt, last quarter)
Debt = 11.2b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.94b
Net Debt = 7.69b USD (calculated: Debt 11.2b - CCE 3.50b)
Enterprise Value = 43.9b USD (36.2b + Debt 11.2b - CCE 3.50b)
Interest Coverage Ratio = 2.55 (Ebit TTM 851.0m / Interest Expense TTM 334.0m)
EV/FCF = 33.39x (Enterprise Value 43.9b / FCF TTM 1.32b)
FCF Yield = 3.00% (FCF TTM 1.32b / Enterprise Value 43.9b)
FCF Margin = 8.74% (FCF TTM 1.32b / Revenue TTM 15.0b)
Net Margin = 1.21% (Net Income TTM 182.0m / Revenue TTM 15.0b)
Gross Margin = 75.50% ((Revenue TTM 15.0b - Cost of Revenue TTM 3.69b) / Revenue TTM)
Gross Margin QoQ = 75.46% (prev 76.40%)
Tobins Q-Ratio = 2.22 (Enterprise Value 43.9b / Total Assets 19.8b)
Interest Expense / Debt = 2.99% (Interest Expense 334.0m / Debt 11.2b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 672.3m (EBIT 851.0m * (1 - 21.00%))
Current Ratio = 1.22 (Total Current Assets 7.61b / Total Current Liabilities 6.23b)
Debt / Equity = 2.94 (Debt 11.2b / totalStockholderEquity, last quarter 3.81b)
Debt / EBITDA = 4.67 (Net Debt 7.69b / EBITDA 1.65b)
Debt / FCF = 5.84 (Net Debt 7.69b / FCF TTM 1.32b)
Total Stockholder Equity = 3.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.92% (Net Income 182.0m / Total Assets 19.8b)
RoE = 4.63% (Net Income TTM 182.0m / Total Stockholder Equity 3.93b)
RoCE = 7.93% (EBIT 851.0m / Capital Employed (Equity 3.93b + L.T.Debt 6.80b))
RoIC = 4.91% (NOPAT 672.3m / Invested Capital 13.7b)
WACC = 8.56% (E(36.2b)/V(47.4b) * Re(10.47%) + D(11.2b)/V(47.4b) * Rd(2.99%) * (1-Tc(0.21)))
Discount Rate = 10.47% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 83.07 | Cagr: 0.28%
[DCF] Terminal Value 77.30% ; FCFF base≈1.06b ; Y1≈1.21b ; Y5≈1.78b
[DCF] Fair Price = 73.52 (EV 25.9b - Net Debt 7.69b = Equity 18.2b / Shares 247.8m; r=8.56% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 3.34 | EPS CAGR: 0.72% | SUE: 0.48 | # QB: 0
Revenue Correlation: -66.30 | Revenue CAGR: -2.04% | SUE: 0.04 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.51 | Chg30d=+0.36% | Revisions=+39% | Analysts=21
EPS next Quarter (2026-12-31): EPS=1.21 | Chg30d=+0.16% | Revisions=+39% | Analysts=20
EPS current Year (2027-06-30): EPS=3.32 | Chg30d=-0.28% | Revisions=+0% | GrowthEPS=+32.4% | GrowthRev=+4.5%
EPS next Year (2028-06-30): EPS=3.93 | Chg30d=+0.29% | Revisions=+42% | GrowthEPS=+18.1% | GrowthRev=+4.3%
[Analyst] Revisions Ratio: +43% (up=35, down=13)